CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.2639
4.12%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0422
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026346 %
Charges from full value of position ($-5.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026346%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004124 %
Charges from full value of position ($0.78)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.2139
Open* 1.1939
1-Year Change* -69.37%
Day's Range* 1.1939 - 1.3339
52 wk Range 0.31-1.75
Average Volume (10 days) 92.03K
Average Volume (3 months) 5.17M
Market Cap 10.51M
P/E Ratio -100.00K
Shares Outstanding 32.21M
Revenue N/A
EPS -0.48
Dividend (Yield %) N/A
Beta 0.93
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 4, 2023 1.2139 0.0600 5.20% 1.1539 1.2339 1.1039
Dec 1, 2023 1.1239 0.0500 4.66% 1.0739 1.1239 1.0639
Nov 30, 2023 1.1139 -0.0200 -1.76% 1.1339 1.1539 1.1039
Nov 29, 2023 1.1239 0.0000 0.00% 1.1239 1.1739 1.1039
Nov 28, 2023 1.1239 0.0100 0.90% 1.1139 1.1339 1.0939
Nov 27, 2023 1.0939 0.0500 4.79% 1.0439 1.1539 1.0439
Nov 24, 2023 1.0939 0.0300 2.82% 1.0639 1.1039 1.0539
Nov 22, 2023 1.0539 -0.0100 -0.94% 1.0639 1.0639 1.0139
Nov 21, 2023 1.0439 0.0100 0.97% 1.0339 1.0639 1.0239
Nov 20, 2023 1.0539 0.0100 0.96% 1.0439 1.0639 1.0239
Nov 17, 2023 1.0639 0.0600 5.98% 1.0039 1.0739 1.0039
Nov 16, 2023 1.0239 0.0000 0.00% 1.0239 1.0539 0.9938
Nov 15, 2023 1.0239 -0.0100 -0.97% 1.0339 1.0739 0.9839
Nov 14, 2023 1.0639 -0.1300 -10.89% 1.1939 1.2039 1.0239
Nov 13, 2023 1.1239 0.0200 1.81% 1.1039 1.1439 1.1039
Nov 10, 2023 1.1039 -0.0200 -1.78% 1.1239 1.1339 1.0939
Nov 9, 2023 1.1339 -0.0500 -4.22% 1.1839 1.1839 1.0939
Nov 8, 2023 1.1739 0.0000 0.00% 1.1739 1.2039 1.1539
Nov 7, 2023 1.1639 -0.0300 -2.51% 1.1939 1.2039 1.1439
Nov 6, 2023 1.1939 -0.0700 -5.54% 1.2639 1.2639 1.1939

Hoth Therapeutics Events

Time (UTC) Country Event
Sunday, March 31, 2024

Time (UTC)

20:00

Country

US

Event

Q4 2023 Hoth Therapeutics Inc Earnings Release
Q4 2023 Hoth Therapeutics Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 0 0 0 0 0
Total Operating Expense 14.1014 7.30197 7.715 2.49553 1.87148
Selling/General/Admin. Expenses, Total 5.78674 3.95884 5.0563 1.22085 1.24058
Research & Development 7.52949 2.88893 2.12012 1.01597 0.58684
Other Operating Expenses, Total 0.78521 0.45421 0.53858 0.25871 0.04406
Operating Income -14.1014 -7.30197 -7.715 -2.49553 -1.87148
Interest Income (Expense), Net Non-Operating 0 -0.00028 0 -0.144
Net Income Before Taxes -14.3137 -7.19782 -7.70464 -2.49553 -2.01548
Net Income After Taxes -14.3137 -7.19782 -7.70464 -2.49553 -2.01548
Net Income Before Extra. Items -14.3137 -7.19782 -7.70464 -2.49553 -2.01548
Net Income -14.3137 -7.19782 -7.70464 -2.49553 -2.01548
Income Available to Common Excl. Extra. Items -14.3137 -7.19782 -7.70464 -2.49553 -2.01548
Income Available to Common Incl. Extra. Items -14.3137 -7.19782 -7.70464 -2.49553 -2.01548
Diluted Net Income -14.3137 -7.19782 -7.70464 -2.49553 -2.01548
Diluted Weighted Average Shares 22.3301 12.3628 9.16458 5.03106 9.42457
Diluted EPS Excluding Extraordinary Items -0.64101 -0.58221 -0.8407 -0.49602 -0.21385
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -0.64101 -0.58221 -0.8407 -0.49602 -0.21385
Other, Net -0.21227 0.10416 0.01064
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 0 0 0 0 0
Total Operating Expense 2.66069 3.38012 3.2532 3.19902 4.26911
Selling/General/Admin. Expenses, Total 1.45837 1.24418 0.88459 1.19662 2.46136
Research & Development 0.98965 1.95651 2.16252 1.78361 1.62685
Other Operating Expenses, Total 0.21268 0.17942 0.20609 0.21879 0.1809
Operating Income -2.66069 -3.38012 -3.2532 -3.19902 -4.26911
Other, Net 0.04169 -0.09998 -0.04285 -0.07686 0.00743
Net Income Before Taxes -2.57151 -3.48009 -3.29605 -3.27588 -4.26168
Net Income After Taxes -2.57151 -3.48009 -3.29605 -3.27588 -4.26168
Net Income Before Extra. Items -2.57151 -3.48009 -3.29605 -3.27588 -4.26168
Net Income -2.57151 -3.48009 -3.29605 -3.27588 -4.26168
Income Available to Common Excl. Extra. Items -2.57151 -3.48009 -3.29605 -3.27588 -4.26168
Income Available to Common Incl. Extra. Items -2.57151 -3.48009 -3.29605 -3.27588 -4.26168
Diluted Net Income -2.57151 -3.48009 -3.29605 -3.27588 -4.26168
Diluted Weighted Average Shares 23.9748 23.9923 23.8878 23.6945 17.6774
Diluted EPS Excluding Extraordinary Items -0.10726 -0.14505 -0.13798 -0.13825 -0.24108
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.10726 -0.14505 -0.13798 -0.13825 -0.24108
Interest Income (Expense), Net Non-Operating 0.0475
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 10.5751 4.78274 2.63509 0.50165 1.23044
Cash and Short Term Investments 10.4311 4.69291 2.49453 0.28262 1.23044
Cash 8.53827 2.62967 1.69087 0.28262 1.23044
Prepaid Expenses 0.09397 0.08984 0.11007 0.01236 0
Total Assets 10.9851 5.24274 2.83613 0.50392 1.23393
Property/Plant/Equipment, Total - Net 0 0.00104 0.00227 0.00349
Total Current Liabilities 0.86779 0.31215 0.44012 0.34895 0.04947
Accounts Payable 0.36096 0.12947 0.40389 0.14228 0.04792
Accrued Expenses 0.50682 0.18268 0.03624 0.20667 0.00154
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 1.10279 0.59715 0.44012 0.34895 0.04947
Total Long Term Debt 0 0 0 0 0
Total Equity 9.88229 4.64559 2.39601 0.15497 1.18447
Redeemable Preferred Stock 0 0 0.00031 0.00017
Common Stock 0.0024 0.00134 0.00101 0.00051 0.00047
Additional Paid-In Capital 43.5895 24.0731 14.6106 4.66515 3.1993
Retained Earnings (Accumulated Deficit) -33.7272 -19.4135 -12.2156 -4.51101 -2.01548
Total Liabilities & Shareholders’ Equity 10.9851 5.24274 2.83613 0.50392 1.23393
Total Common Shares Outstanding 23.9746 13.4385 10.1198 5.0714 9.42457
Other Current Assets, Total 0 0.03048 0.20667
Short Term Investments 1.89284 2.06324 0.80366
Other Long Term Assets, Total 0 0.2
Long Term Investments 0.41 0.41
Note Receivable - Long Term 0 0.05
Other Liabilities, Total 0.235 0.285
Other Equity, Total 0.01759 -0.01535
Total Receivables, Net 0.05
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 8.53526 10.5751 14.7777 17.5689 20.5319
Cash and Short Term Investments 8.29557 10.4311 14.4774 17.4275 20.354
Cash 6.38078 8.53827 12.4454 15.8514 19.3021
Short Term Investments 1.91479 1.89284 2.03197 1.5761 1.05188
Prepaid Expenses 0.18969 0.09397 0.25037 0.14138 0.17786
Total Assets 8.94526 10.9851 15.1877 18.0289 20.9919
Long Term Investments 0.41 0.41 0.41 0.41 0.41
Note Receivable - Long Term 0 0 0.05 0.05
Total Current Liabilities 0.82576 0.86779 1.60665 1.21928 0.75908
Accounts Payable 0.69981 0.36096 1.30138 0.80488 0.58122
Accrued Expenses 0.12595 0.50682 0.30527 0.41439 0.17786
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 1.06076 1.10279 1.84165 1.45428 1.04408
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.235 0.235 0.235 0.235 0.285
Total Equity 7.88449 9.88229 13.3461 16.5746 19.9478
Common Stock 0.0024 0.0024 0.0024 0.00239 0.00231
Additional Paid-In Capital 44.1669 43.5895 43.5709 43.5231 43.6295
Retained Earnings (Accumulated Deficit) -36.2987 -33.7272 -30.2471 -26.951 -23.6751
Other Equity, Total 0.01386 0.01759 0.01979 0.00019 -0.00888
Total Liabilities & Shareholders’ Equity 8.94526 10.9851 15.1877 18.0289 20.9919
Total Common Shares Outstanding 23.9751 23.9746 23.974 23.8727 23.1021
Total Receivables, Net 0.05 0.05 0.05
Preferred Stock - Non Redeemable, Net 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -14.3137 -7.19782 -7.70464 -2.49553 -2.01548
Cash From Operating Activities -12.0901 -6.1332 -4.94722 -2.10263 -0.46524
Cash From Operating Activities 0 0.00104 0.00123 0.00122 0.00019
Non-Cash Items 1.69366 1.19533 2.58656 0.31122 1.50058
Cash Interest Paid 0 0.144
Changes in Working Capital 0.52992 -0.13175 0.16964 0.08046 0.04947
Cash From Investing Activities -0.16536 -1.83765 -0.895 0 -0.30368
Capital Expenditures -0.11697 -0.16746 -0.095 0 -0.30368
Cash From Financing Activities 18.1947 8.72501 7.45046 1.15481 1.99936
Financing Cash Flow Items 0 -0.03151 0.009
Issuance (Retirement) of Stock, Net 18.1947 8.72501 7.45046 1.18632 1.99036
Issuance (Retirement) of Debt, Net 0 0
Net Change in Cash 5.9086 0.7388 1.60825 -0.94782 1.23044
Other Investing Cash Flow Items, Total -0.04839 -1.6702 -0.8
Foreign Exchange Effects -0.03056 -0.01535
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -2.57151 -14.3137 -10.8336 -7.53756 -4.26168
Cash From Operating Activities -2.13649 -12.0901 -8.18793 -5.48505 -2.72259
Cash From Operating Activities 0 0 0 0
Non-Cash Items 0.58049 1.69366 1.4196 1.23678 1.17318
Changes in Working Capital -0.14547 0.52992 1.22608 0.81574 0.36591
Cash From Investing Activities -0.025 -0.16536 -0.14788 0.43124 0.95721
Capital Expenditures -0.025 -0.11697 -0.0995 -0.0079 -0.06955
Other Investing Cash Flow Items, Total 0 -0.04839 -0.04838 0.43914 1.02676
Cash From Financing Activities 0 18.1947 18.1947 18.2946 18.4314
Issuance (Retirement) of Stock, Net 0 18.1947 18.1947 18.2946 18.4314
Foreign Exchange Effects 0.004 -0.03056 -0.04313 -0.01911 0.00647
Net Change in Cash -2.15749 5.9086 9.81571 13.2217 16.6725

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Hoth Therapeutics Company profile

About Hoth Therapeutics Inc

Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a therapy for dermatological disorders including atopic dermatitis (eczema), chronic wounds, psoriasis, asthma and acne. The Company is also focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer, a treatment for asthma and allergies using inhalational administration, a topical treatment for patients with lupus, a treatment for mast-cell derived cancers and anaphylaxis, and a treatment for lung diseases resulting from bacterial infections. The Company's product pipelines include HT-001, HT-003, HT-004 and others. HT-001 is used to treat patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor (EGFR) inhibitor therapy. It is also developing a COVID-19 treatment as well as a diagnostic device for the detection of viruses via a mobile device.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Hoth Therapeutics Inc revenues was not reported. Net loss increased 68% to $10.8M. Higher net loss reflects Research and development increase from $2.1M to $5.4M (expense), Compensation and related expenses (inclu increase from $1.2M to $2.5M (expense), Other general and administrative expense increase of 68% to $606K (expense).

Industry: Pharmaceuticals (NEC)

1 Rockefeller Plz Ste 1039
10020-2003

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

Gold

2,019.52 Price
-0.480% 1D Chg, %
Long position overnight fee -0.0198%
Short position overnight fee 0.0116%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

43,877.35 Price
+4.190% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

15,884.20 Price
+0.400% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.63 Price
-0.630% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading